Core Insights - The Chengdu-Chongqing region has established itself as a significant advanced manufacturing cluster, with the electronic information advanced manufacturing cluster projected to reach a scale of 1.72 trillion yuan in 2024, reflecting a nearly 4% year-on-year growth and accounting for 10.6% of the national total [1][2] - The region has been recognized for its strong industrial capabilities, with five national advanced manufacturing clusters approved in the past five years, including electronic information and biomedicine clusters, contributing to the modernization of the industrial system [1] Industry Developments - The Chengdu-Chongqing electronic information advanced manufacturing cluster has seen a significant increase in its national share from 7.6% in 2016 to 10.6% in 2024, indicating a robust growth trajectory [1] - The cluster includes over 1,300 enterprises that have utilized a public service platform for product supply and demand matching, resulting in financing of approximately 784 million yuan for over 60 companies [1] - The biomedicine sector in the Chengdu Medical City has developed a comprehensive ecosystem with over 600 upstream and downstream collaboration enterprises, focusing on areas such as antibody drugs and medical devices [1] Company Initiatives - The establishment of multiple subsidiaries by Jiuzhou Group in Chongqing, including two in the past three years, highlights the company's commitment to integrating into the Chengdu-Chongqing economic circle and participating in the burgeoning electric vehicle supply chain [1] - Jiuzhou Group aims to leverage a model of "capital cooperation + technology output + scenario operation + industry incubation" to establish a benchmark for cross-regional industrial development [1] - The Chengdu Medical City and Chongqing International Biocity are collaborating to enhance biopharmaceutical research and development, sharing resources and expertise to deepen industry cooperation [2]